These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21962616)

  • 21. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
    Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
    Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL; McFann KK; Johnson AM; Schrier RW
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renin as a target of direct pharmacological block in arterial hypertension].
    Mukhin NA; Fomin VV
    Ter Arkh; 2009; 81(8):5-9. PubMed ID: 19799192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult polycystic liver disease presenting as portal hypertension.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    J Indian Med Assoc; 2004 Jul; 102(7):384-5. PubMed ID: 15717586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potassium chloride mixture may maintain hypokalaemia and hypertension.
    Mandoe MJ; Borg R; Hansen D
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension treatment update: focus on direct renin inhibition.
    Fitzgerald MA
    J Am Acad Nurse Pract; 2011 May; 23(5):239-48. PubMed ID: 21518072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aliskiren: the first renin inhibitor for clinical treatment.
    Jensen C; Herold P; Brunner HR
    Nat Rev Drug Discov; 2008 May; 7(5):399-410. PubMed ID: 18340340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new way to control blood pressure. Inactivating renin, which is made by the kidneys, may open the door to better blood pressure.
    Harv Heart Lett; 2007 May; 17(9):3. PubMed ID: 17517983
    [No Abstract]   [Full Text] [Related]  

  • 30. Autosomal dominant polycystic kidney disease.
    Beebe DK
    Am Fam Physician; 1996 Feb; 53(3):925-31. PubMed ID: 8594868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
    Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
    J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autosomal dominant polycystic kidney disease with primary hyperaldosteronism.
    Bobrie G; Sirieix ME; Day M; Landais P; Lacombe M; Grünfeld JP
    Nephrol Dial Transplant; 1992; 7(7):647-50. PubMed ID: 1323077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
    Fox KA; Rudge FW
    Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the opportunities for blocking the renin-angiotensin system: introduction to a special supplement.
    Weber MA
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S1-6. PubMed ID: 17401311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A young patient with a family history of hypertension.
    Peixoto AJ
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2164-72. PubMed ID: 25092599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension after kidney transplant.
    Mangray M; Vella JP
    Am J Kidney Dis; 2011 Feb; 57(2):331-41. PubMed ID: 21251543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T; Itakura H; Abo Y; Gotou H; Terao S; Keefe DL
    Hypertens Res; 2009 Mar; 32(3):169-75. PubMed ID: 19262478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
    Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension plus hypokalemia should direct the line of thoughts toward Liddle's syndrome].
    Svenarud P; Palmér M
    Lakartidningen; 1999 Oct; 96(43):4667-8. PubMed ID: 10575877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.